期刊
CLINICAL INFECTIOUS DISEASES
卷 52, 期 5, 页码 E103-E120出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciq257
关键词
-
资金
- The Infectious Diseases Society of America
- UpToDate
- American Urological Association
- Bionorica
- Daiichi
- Sankyo
- Janssen Cilag
- Johnson Johnson
- OM Pharma
- Pierre Fabre
- Sanofi Aventis
- Zambon
- Mer-Lion Pharmaceuticals
- Rosen Pharma
- Cubist
- Pfizer Pharmaceuticals
A Panel of International Experts was convened by the Infectious Diseases Society of America (IDSA) in collaboration with the European Society for Microbiology and Infectious Diseases (ESCMID) to update the 1999 Uncomplicated Urinary Tract Infection Guidelines by the IDSA. Co-sponsoring organizations include the American Congress of Obstetricians and Gynecologists, American Urological Association, Association of Medical Microbiology and Infectious Diseases-Canada, and the Society for Academic Emergency Medicine. The focus of this work is treatment of women with acute uncomplicated cystitis and pyelonephritis, diagnoses limited in these guidelines to premenopausal, non-pregnant women with no known urological abnormalities or co-morbidities. The issues of in vitro resistance prevalence and the ecological adverse effects of antimicrobial therapy (collateral damage) were considered as important factors in making optimal treatment choices and thus are reflected in the rankings of recommendations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据